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BRIEF COMMUNICATION
DISTRIBUTION OF HEPATITIS C VIRUS GENOTYPES AMONG BLOOD DONORS
FROM MID-WEST REGION OF BRAZIL
Regina M.B. MARTINS(1), Sheila A. TELES(1), Nara R. FREITAS(1), Ana R.C. MOTTA-CASTRO(2), Francisco J.D. SOUTO(3),
Aparecida MUSSI(3), Regina M.S. AMORIM(4) & Cláudia R.F. MARTINS(4)
SUMMARY
In order to investigate the hepatitis C virus (HCV) genotypes in mid-west region of Brazil, 250 anti-HCV positive blood
donors were studied. Among them, the anti-HCV serological status was confirmed in 205 (82%). HCV RNA was detected in 165
samples, which were genotyped. HCV types 1, 2 and 3 were found in 67.9%, 3% and 29.1% of the donors, respectively. In Goiás
state, subtype 1a (50%) was the most prevalent, followed by subtypes 3a (30.9%) and 1b (16.7%). In Mato Grosso state, subtype
1a was also predominant (41%), followed by subtypes 1b (29.5%) and 3a (25%). In Mato Grosso do Sul state, subtypes 1a and 1b
were detected equally (36.8%), followed by 3a (21.1%). Subtype 2b was rare (2.4%, 4.5% and 5.3%, respectively). In Distrito
Federal, subtype 3a (39%) was more frequent than 1a (31.7%) and the remaining (29.3%) belonged to subtype 1b.
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INTRODUCTION
Hepatitis C virus (HCV) is a well-known agent of chronic infection,
including cirrhosis and hepatocellular carcinoma, with an estimated
170-200 million carries around the world1. HCV has a positive-sense,
single-stranded RNA genome that presents a high mutation rate (1.44
x 10-3 substitutions/site/year). HCV strains isolates worldwide have
been classified into six different genotypes (1 to 6), each comprising
multiple subtypes (designated a, b, c, etc)11. HCV genotypes can be
determined directly by molecular typing or indirectly by serological
typing. Current genotyping methods include amplification of defined
regions of genome, such as 5’ non-coding (NC), core, envelope 1 and
non-structural (NS) 5B, by polymerase chain reaction (PCR) followed
by nucleotide sequencing or hybridization with type-specific probes
or digestion with restriction enzymes and restriction fragment length
polymorphism analysis or reamplification with type-specific primers.
Indirect HCV serological typing is based on the detection of genotype-
specific antibodies directed to epitopes encoded by NS4 or core regions
of the genome. Although this has some advantages, such as the
simplicity of the assay (ELISA) and low risk of contamination, it is
not able to identify HCV subtypes15.
The genotype determination is a relevant predictive parameter of
response to antiviral treatment since genotype 1 is associated with a
lower sustained virologic response (40 - 45%) compared to genotypes
2 and 3, whose sustained virologic response is 70 - 80% with
peginterferon and ribavirin combination therapy for 48 and 24 weeks,
respectively1. In addition, the various genotypes have distinct
geographical distributions. Although HCV genotypes 1, 2 and 3 appear
to have a worldwide distribution, their relative prevalence varies from
one geographic area to another. HCV genotype 4 is found in the Middle
East and North Africa; and genotypes 5 and 6 in South Africa and
Asia, respectively11,15.
In Brazil, a continental country, previous studies were carried out
in Rio de Janeiro, São Paulo (southeastern region), Porto Alegre (south
region), Natal, Salvador and Recife (northeast region)2,3,6,8-10,13. Given
the limited amount of data concerning HCV genotypes in mid-west
region7, we decided to investigate the distribution of HCV genotypes
in blood donors from the four states of Mid-West region: Mato Grosso,
Mato Grosso do Sul, Goiás and Distrito Federal.
MATERIALS AND METHODS
A total of 250 anti-HCV positive serum samples from volunteer
blood donors were obtained in the States of Mato Grosso (n = 65), Mato
Grosso do Sul (n = 63), Goiás (n = 65) and Distrito Federal (n = 57)
between March 2001 and July 2002. The studied donors ranged in age
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from 18 to 57 years old (average 29.5 years). The majority of them
(75%) were men. The study was approved by the Ethical Committee of
the Federal University of Goiás. Anti-HCV positive samples by ELISA
were retested by line immunoassay (INNO-LIA HCV Ab III,
Innogenetics) and were also submitted to RNA extraction, reverse
transcription, and nested PCR with primers complementary to the
conserved area of the 5’ NC region of HCV, essentially as described
previously5. Positive samples were genotyped by line probe assay (INNO-
LiPA HCV III, Innogenetics NV, Ghent, Belgium). Chi-square test or
Fisher’s exact test were used to analyze the HCV genotype data.
RESULTS AND DISCUSSION
The anti-HCV-ELISA serological status was confirmed with the
anti-HCV-LIA antibody assay in 205 (82%) of the 250 blood donors
studied, while the remaining was negative (16%) or indeterminate (2%).
The HCV RNA positivity was 80.5% among anti-HCV-positive
individuals. Figure 1 shows the distribution of HCV genotypes among
165 HCV-RNA-positive blood donors. In Goiás (n = 42), subtype 1a
(50%) was the most prevalent, followed by subtypes 3a (30.9%) and
1b (16.7%). This genotype distribution, with subtype 1a predominance,
was similar to that found (41%) in Mato Grosso (n = 44), however,
there, subtype 1b (29.5%) was more frequent than 3a (25%). In Mato
Grosso do Sul (n = 38), subtypes 1a and 1b were detected equally
(36.8%), followed by 3a (21.1%). Subtype 2b was rare (2.4%, 4.5%
and 5.3%, respectively). In Distrito Federal (n = 41), subtype 3a (39%)
was found more frequently than 1a (31.7%) and the remaining (29.3%)
belonged to subtype 1b, however these differences were not statistically
significant (p > 0.05).
In the present study, the use of the anti-HCV LIA 3.0 as a
supplement test confirmed the occurrence of false positive results with
anti-HCV ELISA 3.0 in 18% of the anti-HCV reactive samples in the
screening test. Despite the incremental improvements in sensibility
and specificity of the third generation assays, the proportion of positivity
confirmation with HCV version 3.0 ELISA ranges 17 - 80% among
low-risk populations such as blood donors4,14. The finding of HCV RNA
positivity in approximately 80% of the anti-HCV-positive blood donors
was in agreement with that reported elsewhere12.
In mid-west region, the proportions of blood donors with HCV
types 1, 2 and 3 were 67.9%, 3% and 29.1%, respectively. These data
were similar to those previously found in blood donors or non-blood
donors in Brazil, where genotype 1 infection is predominant2,3,6-10,13.
This distribution was also similar to that detected in the United States
and many European countries, where genotypes 1 (1a and 1b) and 3
(3a) have spread as a result of transmission though blood transfusion
and needle-sharing between infected drug users over the past 30-70
years11,15. In addition, HCV subtypes prevalence varies from one
geographic region to another or even though in the same region7,9,10,15.
In Goiás and Mato Grosso, subtype 1a was dominant, and it was
followed by subtypes 3a and 1b, respectively. In Mato Grosso do Sul,
subtypes 1a and 1b were the most frequent, followed by 3a, while in
Distrito Federal this subtype was the most common, followed by 1a
and 1b. Regarding the characteristics of the studied population, there
were no significant differences between gender and age of the blood
Fig. 1 - Hepatitis C genotypes in blood donors from Mid-west region of Brazil. A: Goiás state; B: Mato Grosso state; C: Mato Grosso do Sul state; D: Distrito Federal
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donors infected with subtypes 1a, 1b and 3a (data not shown). In
addition, risk factors such as injecting drug use or blood transfusion
can influence HCV subtypes distribution11,15, but they were not evaluated
in this study.
Although the number of samples studied was small, these findings
indicate variation in genotype circulation in mid-west region of Brazil.
Further molecular studies with different HCV genomic regions are
necessary to provide a better understanding of the dynamics of this
infection in Central Brazil.
RESUMO
Distribuição dos genótipos do vírus da hepatite C em doadores
de sangue na Região Centro-Oeste do Brasil
Com objetivo de determinar os genótipos do vírus da hepatite C
(HCV) circulantes na Região Centro-Oeste do Brasil, 250 doadores de
sangue anti-HCV positivos foram estudados. Dentre eles, a positividade
para anti-HCV foi confirmada em 205 (82%). O RNA-HCV foi
detectado em 165 amostras, as quais foram genotipadas. Os tipos 1, 2
e 3 do HCV foram encontrados em 67,9%, 3% e 29,1% dos doadores,
respectivamente. No Estado de Goiás, o subtipo 1a (50%) foi o mais
prevalente, seguido pelos subtipos 3a (30,9%) e 1b (16,7%). No Estado
de Mato Grosso, o subtipo 1a (41%) foi também predominante, seguido
pelos subtipos 1b (29,5%) e 3a (25%). No Estado de Mato Grosso do
Sul, os subtipos 1a e 1b foram igualmente detectados (36,8%), seguidos
por 3a (21,1%). O subtipo 2b foi raro (2,4%, 4,5% e 5,3%,
respectivamente). No Distrito Federal, o subtipo 3a (39%) foi mais
freqüente que 1a (31,7%), sendo o restante (29,3%) identificado como
subtipo 1b.
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